HES1 and central nervous system cancer: Further study demonstrated that after treating glioma U87 and U128 cells with TIG, the miRNA-199b-5p level obviously increased and the level of HES family BHLH transcription factor 1 (HES1), a target of miRNA-199b-5p, obviously decreased.